Center for Biological Diversity blasts CAFE rollback timing
The Center for Biological Diversity called the pending CAFE rollback reckless amid high pump prices. The group says cleaner technology feasibility is being ignored.
Dan Becker of the Center for Biological Diversity’s Safe Climate Transport Campaign, quoted by AP, called the pending CAFE final rule a reckless rollback that ignores clean-technology feasibility and hits consumers when pump prices are already high. That is the sharpest NGO climate quote heading into Monday. CBD and peer groups often sue on the administrative record. Their public statement previews the legal theory: feasibility and consumer-cost analyses they say NHTSA underweighted. The agency’s technical documents will be exhibit A on both sides. Timing politics — war-risk gas plus rollback — is intentional messaging from opponents. AP carries CBD’s rebuke alongside the administration’s production-and-price pitch. Feasibility claims will be fought with dueling technical appendices, not slogans alone. The Center for Biological Diversity called the pending CAFE rollback reckless amid high pump prices. The group says cleaner technology feasibility is being ignored.
The group says cleaner technology feasibility is being ignored.
Associated Press carries the Center for Biological Diversity’s rebuke that the pending CAFE rollback is reckless amid high pump prices, set beside the administration’s production-and-price pitch in Washington Examiner coverage. The group says cleaner-technology feasibility is being ignored.
Feasibility claims will be fought with dueling technical appendices, not slogans alone. Litigators on both sides will mine the final rule’s cost-benefit tables once they post, and CBD’s timing critique links household fuel pain to a policy that could raise long-run gallons burned.
Center for Biological Diversity counsel will cite the final CAFE cost-benefit appendix when arguing the rollback ignored feasible cleaner technology while households still face elevated pump prices.
Where outlets agree AP carries CBD’s rebuke alongside the administration’s production-and-price pitch.
Where they differ Feasibility claims will be fought with dueling technical appendices, not slogans alone.